(Q35797114)

10 August 2017

title

COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin (English)

1 reference

10 August 2017

1 reference

Graham A Colditz

5

0 references

Susan E. Hankinson

series ordinal

6

object named as

Susan E Hankinson

1 reference

10 August 2017

7

Rulla M Tamimi

1 reference

10 August 2017

3

Stuart J Schnitt

1 reference

10 August 2017

1

Michelle D Holmes

1 reference

10 August 2017

4

Laura Collins

1 reference

10 August 2017

Wendy Y Chen

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

5 July 2011

1 reference

Breast Cancer Research and Treatment

10 August 2017

published in

1 reference

10 August 2017

volume

130

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

657-662

1 reference

Aspirin intake and survival after breast cancer

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

Aspirin use and survival after diagnosis of colorectal cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

Survival effects of cyclooxygenase-2 and 12-lipooxygenase in Egyptian women with operable breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

NSAIDs and breast cancer recurrence in a prospective cohort study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

Prospective study of regular aspirin use and the risk of breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3292350

NSAID use and survival after breast cancer diagnosis in post-menopausal women.

27 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1651-7

Cox-2 expression on tissue microarray of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1651-7

Cyclooxygenase-2 expression in postmastectomy chest wall relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1651-7

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1651-7

Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1651-7

Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER-negative, but not ER-positive, breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1651-7

Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1651-7

Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1651-7

Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1651-7

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21728052

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

COX-2 expression in invasive breast cancer: correlation with prognostic parameters and outcome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21728052

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10549-011-1651-7

1 reference

10 August 2017

1 reference

10 August 2017

1 reference